| REGISTERED NUMBER: |
| Financial Statements |
| for the Year Ended 31 December 2024 |
| for |
| Oncoland Limited |
| REGISTERED NUMBER: |
| Financial Statements |
| for the Year Ended 31 December 2024 |
| for |
| Oncoland Limited |
| Oncoland Limited (Registered number: 00865608) |
| Contents of the Financial Statements |
| for the Year Ended 31 December 2024 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 4 |
| Oncoland Limited |
| Company Information |
| for the Year Ended 31 December 2024 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| Oncoland Limited (Registered number: 00865608) |
| Balance Sheet |
| 31 December 2024 |
| 2024 | 2023 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Property, plant and equipment | 4 |
| Investments | 5 |
| Investment property | 6 |
| CURRENT ASSETS |
| Inventories |
| Debtors | 7 |
| Cash at bank and in hand |
| CREDITORS |
| Amounts falling due within one year | 8 |
| NET CURRENT (LIABILITIES)/ASSETS | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
9 |
( |
) |
( |
) |
| PROVISIONS FOR LIABILITIES | 11 | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 12 |
| Revaluation reserve | 13 |
| Capital redemption reserve | 13 |
| Fair value reserve | 13 |
| Retained earnings | 13 |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| Oncoland Limited (Registered number: 00865608) |
| Balance Sheet - continued |
| 31 December 2024 |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Oncoland Limited (Registered number: 00865608) |
| Notes to the Financial Statements |
| for the Year Ended 31 December 2024 |
| 1. | STATUTORY INFORMATION |
| Oncoland Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Turnover |
| Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Tangible fixed assets |
| Land is stated at fair value however it is not being depreciated as it has an unlimited life. |
| Buildings, plant and machinery etc are stated at cost less accumulated depreciation and accumulated impairment losses. |
| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter. |
| Buildings | 4% on reducing balance basis |
| Plant and machinery etc | 5%-25% on reducing balance basis |
| Land | Not depreciated |
| Investment property |
| In accordance with the requirements of FRS 102 properties which are considered to be held to earn rentals or for capital appreciation or both have been reclassified as investment properties at 1January 2015, the FRS 102 transition date. |
| The company carries its investment property at fair value, with changes in fair value being recognised in profit or loss. The fair value at 31 December 2024 of the properties has been determined by the directors of the company. The directors have adopted a valuation model based upon a multiple of the gross rental income adjusted where appropriate for any individual property market considerations. The directors over-ride their valuation model where independent valuation specialists have been engaged. |
| Inventories |
| Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Oncoland Limited (Registered number: 00865608) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 2. | ACCOUNTING POLICIES - continued |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Hire purchase and leasing commitments |
| Property, plant and equipment acquired under finance leases or hire purchase contracts are capitalised and depreciated in the same manner as other tangible fixed assets. The related obligations, net of future finance charges, are included in creditors. |
| Government grants |
| The company is in receipt of monies from the Government in the form of the Single Payment Scheme and monies received are recognised in the year of claim. |
| Fixed asset investments |
| Investments in shares are accounted for at cost less accumulated impairment losses. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | PROPERTY, PLANT AND EQUIPMENT |
| Plant and |
| Land and | machinery |
| buildings | etc | Totals |
| £ | £ | £ |
| COST OR VALUATION |
| At 1 January 2024 |
| Additions |
| Disposals | ( |
) | ( |
) |
| At 31 December 2024 |
| DEPRECIATION |
| At 1 January 2024 |
| Charge for year |
| Eliminated on disposal | ( |
) | ( |
) |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| Oncoland Limited (Registered number: 00865608) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 4. | PROPERTY, PLANT AND EQUIPMENT - continued |
| Cost or valuation at 31 December 2024 is represented by: |
| Plant and |
| Land and | machinery |
| buildings | etc | Totals |
| £ | £ | £ |
| Valuation in 2013 | 5,188,254 | - | 5,188,254 |
| Valuation in 2014 | 532,472 | - | 532,472 |
| Valuation in 2015 | 1,386,271 | - | 1,386,271 |
| Valuation in 2019 | 758,730 | - | 758,730 |
| Valuation in 2022 | 663,601 | - | 663,601 |
| Cost | 3,820,017 | 4,312,128 | 8,132,145 |
| 12,349,345 | 4,312,128 | 16,661,473 |
| If land and buildings had not been revalued they would have been included at the following historical cost: |
| 2024 | 2023 |
| £ | £ |
| Cost | 3,322,744 | 3,218,846 |
| Aggregate depreciation | 1,340,290 | 1,259,127 |
| Value of land in freehold land and buildings | 487,273 | 487,273 |
| Land and buildings were valued on a fair value basis on 31 December 2024 by the directors . |
| Fixed assets, included in the above, which are held under hire purchase contracts are as follows: |
| Plant and |
| machinery |
| etc |
| £ |
| COST OR VALUATION |
| At 1 January 2024 |
| Additions |
| At 31 December 2024 |
| DEPRECIATION |
| At 1 January 2024 |
| Charge for year |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| Oncoland Limited (Registered number: 00865608) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 5. | FIXED ASSET INVESTMENTS |
| Interest |
| in other |
| Investments |
| £ |
| COST |
| At 1 January 2024 |
| and 31 December 2024 | 125,698 |
| PROVISIONS |
| At 1 January 2024 |
| and 31 December 2024 | 125,694 |
| NET BOOK VALUE |
| At 31 December 2024 | 4 |
| At 31 December 2023 | 4 |
| 6. | INVESTMENT PROPERTY |
| Total |
| £ |
| FAIR VALUE |
| At 1 January 2024 |
| Revaluations | (496,375 | ) |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| Investment properties are stated in the balance sheet at their aggregate fair value based on valuations carried out at 31 December 2024 by the directors. If investment property had not been revalued it would have been included at the historical cost of £ £8,169,731 (2024- £ 8,169,731). |
| 7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade debtors |
| Other debtors |
| Included in other debtors is a deferred tax asset of £97,644 (2023 - £97,644). |
| Oncoland Limited (Registered number: 00865608) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Bank loans and overdrafts |
| Hire purchase contracts |
| Trade creditors |
| Amounts owed to group undertakings |
| Taxation and social security |
| Other creditors |
| 9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Bank loans and overdrafts |
| Hire purchase contracts |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Bank loans | 6,836,083 | 7,116,424 |
| 10. | SECURED DEBTS |
| The following secured debts are included within creditors: |
| 2024 | 2023 |
| £ | £ |
| Bank loans and overdrafts |
| Hire purchase contracts | 560,703 | 178,225 |
| Nature of Security |
| The hire purchase contracts are secured by the financed assets. |
| Bank loans are secured by legal charge over company's properties and guarantees given by F.C. Stark Limited, Oncoland Energy Limited and personal guarantees from the directors. |
| 11. | PROVISIONS FOR LIABILITIES |
| 2024 | 2023 |
| £ | £ |
| Deferred tax |
| Accelerated capital allowances | ( |
) |
| Unrealised surplus on |
| revaluation of investment |
| properties | 658,522 | 777,652 |
| Unrealised surplus on |
| revaluation of |
| trading properties | 143,982 | 194,381 |
| 619,989 | 1,077,670 |
| Oncoland Limited (Registered number: 00865608) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 11. | PROVISIONS FOR LIABILITIES - continued |
| Deferred |
| tax |
| £ |
| Balance at 1 January 2024 |
| Provided during year | ( |
) |
| Charge to other comprehensive | (50,399 | ) |
| income |
| Balance at 31 December 2024 |
| 12. | CALLED UP SHARE CAPITAL |
| Allotted and issued: |
| Number: | Class: | Nominal | 2024 | 2023 |
| value: | £ | £ |
| Ordinary A | £1 | 234,000 | 234,000 |
| Ordinary B | £1 | 339,432 | 339,432 |
| 573,432 | 573,432 |
| 13. | RESERVES |
| Capital | Fair |
| Retained | Revaluation | redemption | value |
| earnings | reserve | reserve | reserve | Totals |
| £ | £ | £ | £ | £ |
| At 1 January 2024 | 15,437,080 |
| Deficit for the year | ( |
) | ( |
) |
| Transfer deferred tax on |
| investment property | (119,130 | ) | - | - | 119,130 | - |
| Transfer revaluation on |
| investment property | 496,375 | - | - | (496,375 | ) | - |
| Deferred tax on trading |
| property | - | 50,399 | - | - | 50,399 |
| At 31 December 2024 | 15,039,222 |
| 14. | CONTINGENT LIABILITIES |
| C Hoare & Co |
| The company is a guarantor to a guarantee limited to £4,430,000 plus interest and charges provided to C Hoare & Co in respect of the bank borrowing of F.C. Stark Limited, the company's parent company, supported by legal charge over company property. |
| 15. | RELATED PARTY DISCLOSURES |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Oncoland Limited (Registered number: 00865608) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 15. | RELATED PARTY DISCLOSURES - continued |
| Subsidiary (not exempt) |
| The company made sales of goods and services to Watchingwell Farms Limited of £790,637 (2023 - £868,409) |
| The company purchased goods and services totalling £118,245 (2023- £148,953) from Watchingwell Farms Limited. |
| 16. | PARENT COMPANY |
| The parent company is F.C. Stark Limited. |